ID   NT4
AC   CVCL_JA58
DR   Wikidata; Q54931110
RX   PubMed=10910070;
RX   PubMed=18829490;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
RX   PubMed=10910070;
RA   Reilly, R. Todd
RA   Gottlieb, Morris Ben Chancy
RA   Ercolini, Anne M.
RA   Machiels, Jean-Pascal H.
RA   Kane, Colin Edward
RA   Okoye, Francesca Ijeoma
RA   Muller, William J.
RA   Dixon, Katharine H.
RA   Jaffee, Elizabeth Marion
RT   "HER-2/neu is a tumor rejection target in tolerized HER-2/neu
RT   transgenic mice.";
RL   Cancer Res. 60:3569-3576(2000).
//
RX   PubMed=18829490; DOI=10.1158/1078-0432.CCR-07-4672; PMCID=PMC2570093;
RA   Song, Hong
RA   Shahverdi, Karineh
RA   Huso, David L.
RA   Wang, Yu-Chuan
RA   Fox, James J.
RA   Hobbs, Robert F.
RA   Gimi, Barjor
RA   Gabrielson, Kathleen L.
RA   Pomper, Martin G.
RA   Tsui, Benjamin M.
RA   Bhujwalla, Zaver
RA   Reilly, R. Todd
RA   Sgouros, George
RT   "An immunotolerant HER-2/neu transgenic mouse model of metastatic
RT   breast cancer.";
RL   Clin. Cancer Res. 14:6116-6124(2008).
//